- Home
- JCAP vs TXG Comparison
JCAP vs TXG Comparison
Compare JCAP & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCAP
- TXG
- Stock Information
- Founded
- JCAP 2002
- TXG 2012
- Country
- JCAP United States
- TXG United States
- Employees
- JCAP N/A
- TXG N/A
- Industry
- JCAP
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- JCAP
- TXG Industrials
- Exchange
- JCAP NYSE
- TXG Nasdaq
- Market Cap
- JCAP 1.2B
- TXG 1.3B
- IPO Year
- JCAP 2025
- TXG 2019
- Fundamental
- Price
- JCAP $16.65
- TXG $12.80
- Analyst Decision
- JCAP
- TXG Buy
- Analyst Count
- JCAP 0
- TXG 12
- Target Price
- JCAP N/A
- TXG $14.13
- AVG Volume (30 Days)
- JCAP 627.5K
- TXG 4.1M
- Earning Date
- JCAP 01-01-0001
- TXG 08-07-2025
- Dividend Yield
- JCAP N/A
- TXG N/A
- EPS Growth
- JCAP N/A
- TXG N/A
- EPS
- JCAP N/A
- TXG N/A
- Revenue
- JCAP $485,042,000.00
- TXG $624,662,000.00
- Revenue This Year
- JCAP N/A
- TXG N/A
- Revenue Next Year
- JCAP N/A
- TXG $6.06
- P/E Ratio
- JCAP $6.79
- TXG N/A
- Revenue Growth
- JCAP 29.09
- TXG N/A
- 52 Week Low
- JCAP $16.40
- TXG $6.78
- 52 Week High
- JCAP $19.55
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- JCAP N/A
- TXG 66.48
- Support Level
- JCAP N/A
- TXG $11.73
- Resistance Level
- JCAP N/A
- TXG $13.14
- Average True Range (ATR)
- JCAP 0.00
- TXG 0.75
- MACD
- JCAP 0.00
- TXG 0.03
- Stochastic Oscillator
- JCAP 0.00
- TXG 87.24
About JCAP JEFFERSON CAPITAL INC
Jefferson Capital Inc is a analytically driven purchaser and manager of charged-off and insolvency consumer accounts with operations in the United States, Canada, the United Kingdom and Latin America. Its accounts purchase are the unpaid obligations of individuals owed to credit grantors, which include banks, non-bank consumer lenders, auto finance companies, utilities and telecom companies.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).